C22 Malignant neoplasm of liver and intrahepatic bile ducts

Name of the Condition

• Malignant neoplasm of liver and intrahepatic bile ducts
• Liver cancer (intrahepatic bile duct involvement)

Summary

Malignant neoplasm of the liver and intrahepatic bile ducts refers to cancerous growths originating in the liver tissue or the bile ducts within the liver. This condition is a type of primary liver cancer that can affect liver function and may spread to nearby tissues or other parts of the body if untreated.

Causes

The exact cause involves genetic mutations in liver or bile duct cells leading to uncontrolled cell growth. Contributing factors may include chronic liver disease, environmental exposures, and genetic predispositions.

Risk Factors

• Chronic viral hepatitis (hepatitis B or C)
• Cirrhosis of the liver
• Excessive alcohol consumption
• Non-alcoholic fatty liver disease (NAFLD)
• Aflatoxin exposure
• Age, particularly over 50
• Male gender
• Family history of liver cancer

Symptoms

• Unexplained weight loss
• Abdominal pain or swelling
• Jaundice (yellowing of skin/eyes)
• Loss of appetite
• Nausea or vomiting
• Fatigue
• Dark urine or pale stools

Diagnosis

Diagnosis involves a physical examination by a healthcare provider, followed by imaging tests (e.g., ultrasound, CT, MRI) to detect abnormalities. A biopsy of liver tissue may be performed to confirm malignancy, and blood tests (e.g., liver function tests, tumor markers) may assess liver health and cancer presence.

Treatment Options

Treatment depends on cancer stage, liver function, and overall health. Options may include surgery (resection or transplant), ablation, embolization, radiation therapy, targeted therapy, or chemotherapy. Multidisciplinary care is often recommended.

Prognosis and Follow-Up

Prognosis varies based on cancer stage, liver function, and treatment response. Regular follow-up with imaging and blood tests is typically recommended to monitor for recurrence or progression. Early detection and treatment may improve outcomes.

Complications

• Liver failure
• Spread to other organs (metastasis)
• Bile duct obstruction
• Ascites (fluid buildup in abdomen)
• Portal hypertension

Lifestyle & Prevention

• Limit alcohol consumption
• Maintain a healthy weight
• Get vaccinated for hepatitis B
• Avoid aflatoxin-contaminated foods
• Manage chronic liver conditions (e.g., hepatitis C treatment)
• Regular health screenings for high-risk individuals

When to Seek Professional Help

Seek medical attention for persistent abdominal pain, unexplained weight loss, jaundice, or other symptoms listed above. Early evaluation is critical for timely diagnosis and treatment.

Tips for Medical Coders

Code C22 is assigned for malignant neoplasms of the liver and intrahepatic bile ducts. Documentation should specify the primary site (liver vs. intrahepatic bile ducts) and any associated conditions (e.g., cirrhosis, hepatitis) to support accurate coding. Ensure alignment with ICD-10-CM guidelines for primary vs. secondary liver cancers.